Oregon passed Senate Bill 1527 as part of the 2026 regular session. The legislation prohibits group and individual health plans from imposing deductibles, copayments, coinsurance, or other out-of-pocket costs for medically necessary cervical cancer screenings and follow-up examinations if reimbursed by the plan. The mandate applies even if different samples are used, or the follow-up exam occurs on a different date than the initial screening. The requirement applies to policies and certificates issued, renewed, or extended on or after January 1, 2027.
Employers with health benefit plans governed by state law should be aware of these mandates and can contact their carrier or TPA for further details. Employee welfare benefit plans governed by ERISA are exempt from Senate Bill 1527, as are additional coverages, based on the definition of health benefit plans in the mandate.
For the legislative text, read SB1527 2026 Regular Session.